Guggenheim Capital LLC decreased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,065,774 shares of the company’s stock after selling 32,232 shares during the period. Guggenheim Capital LLC owned about 0.12% of Colgate-Palmolive Company worth $69,744,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in CL. First Personal Financial Services boosted its position in Colgate-Palmolive Company by 9.5% in the third quarter. First Personal Financial Services now owns 31,587 shares of the company’s stock worth $2,342,000 after buying an additional 2,745 shares during the period. Toronto Dominion Bank boosted its position in Colgate-Palmolive Company by 33.7% in the third quarter. Toronto Dominion Bank now owns 82,251 shares of the company’s stock worth $6,106,000 after buying an additional 20,733 shares during the period. State of New Jersey Common Pension Fund D boosted its position in Colgate-Palmolive Company by 43.8% in the third quarter. State of New Jersey Common Pension Fund D now owns 1,084,000 shares of the company’s stock worth $80,368,000 after buying an additional 330,000 shares during the period. Rhumbline Advisers boosted its position in Colgate-Palmolive Company by 3.4% in the third quarter. Rhumbline Advisers now owns 1,445,623 shares of the company’s stock worth $107,178,000 after buying an additional 47,265 shares during the period. Finally, WINTON GROUP Ltd purchased a new position in Colgate-Palmolive Company during the third quarter worth about $2,498,000. 73.24% of the stock is currently owned by institutional investors.
Shares of Colgate-Palmolive Company (NYSE:CL) opened at 73.67 on Friday. The company has a market cap of $65.04 billion, a PE ratio of 27.08 and a beta of 0.70. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $75.38. The firm’s 50 day moving average is $71.75 and its 200 day moving average is $69.62.
Colgate-Palmolive Company (NYSE:CL) last posted its quarterly earnings results on Friday, January 27th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.75. The business had revenue of $3.72 billion for the quarter, compared to analyst estimates of $3.87 billion. Colgate-Palmolive Company had a net margin of 16.06% and a return on equity of 4,897.09%. The firm’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same quarter last year, the business posted $0.73 EPS. On average, equities analysts predict that Colgate-Palmolive Company will post $2.93 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Investors of record on Friday, April 21st will be given a dividend of $0.40 per share. This is a positive change from Colgate-Palmolive Company’s previous quarterly dividend of $0.39. The ex-dividend date is Wednesday, April 19th. This represents a $1.60 annualized dividend and a dividend yield of 2.17%. Colgate-Palmolive Company’s dividend payout ratio (DPR) is currently 57.35%.
A number of research firms have recently issued reports on CL. B. Riley cut their target price on shares of Colgate-Palmolive Company from $78.00 to $74.00 and set a “neutral” rating for the company in a research note on Sunday, January 29th. Barclays PLC set a $75.00 target price on shares of Colgate-Palmolive Company and gave the company a “hold” rating in a research note on Saturday, February 18th. Zacks Investment Research upgraded shares of Colgate-Palmolive Company from a “sell” rating to a “hold” rating in a research note on Friday. Citigroup Inc lifted their target price on shares of Colgate-Palmolive Company from $70.00 to $75.00 and gave the company a “neutral” rating in a research note on Tuesday, March 21st. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive Company in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have assigned a buy rating to the company’s stock. Colgate-Palmolive Company currently has a consensus rating of “Hold” and a consensus target price of $74.77.
In related news, Director Stephen I. Sadove sold 8,000 shares of the stock in a transaction that occurred on Friday, February 3rd. The shares were sold at an average price of $66.00, for a total transaction of $528,000.00. Following the sale, the director now owns 33,761 shares in the company, valued at approximately $2,228,226. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 868 shares of the stock in a transaction that occurred on Monday, January 9th. The stock was sold at an average price of $66.62, for a total transaction of $57,826.16. Following the sale, the insider now owns 36,813 shares in the company, valued at approximately $2,452,482.06. The disclosure for this sale can be found here. Insiders have sold a total of 12,701 shares of company stock worth $838,766 in the last quarter. 1.05% of the stock is currently owned by company insiders.
About Colgate-Palmolive Company
Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.